Literature DB >> 15994274

TB screening and anti-TNF alpha treatment.

G Provenzano, M C Ferrante, G Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15994274      PMCID： PMC1747457          DOI： 10.1136/thx.2005.042457

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  TB screening and anti-TNFalpha treatment.

Authors:  D J Dhasmana; J Nash; J C Bradley; D Creer; G Provenzano
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

2.  Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.

Authors:  Cláudia Diniz Lopes Marques; Ângela Luzia Branco Pinto Duarte; Virginia Maria Barros de Lorena; Joelma Rodrigues Souza; Wayner Vieira Souza; Yara de Miranda Gomes; Eduardo Maia Freese de Carvalho
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

3.  Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment.

Authors:  M Bocchino; A Matarese; B Bellofiore; P Giacomelli; G Santoro; N Balato; F Castiglione; R Scarpa; F Perna; G Signoriello; D Galati; A Ponticiello; A Sanduzzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-10       Impact factor: 3.267

4.  Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.

Authors:  Christiane Aguiar Nobre; Maria Roseli Monteiro Callado; José Rubens Costa Lima; Kirla Wagner Poti Gomes; Germana Vasconcelos Mesquita Martiniano; Walber Pinto Vieira
Journal:  Rheumatol Int       Date:  2011-08-07       Impact factor: 2.631

5.  Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha.

Authors:  Osman Elbek; Meral Uyar; Neriman Aydin; Sermin Börekçi; Nazan Bayram; Hasan Bayram; Oner Dikensoy
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.